Acrow Limited
Acrow Limited (ACF.AX) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Acrow Limited (ACF.AX), covering cash flow, earnings, and balance sheets.
Acrow Limited (ACF.AX) Income Statement & Financial Overview
Analyze Acrow Limited’s ACF.AX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $99.74M | $93.37M | $75.33M | $74.48M |
| Cost of Revenue | $75.70M | $66.58M | $57.25M | $57.23M |
| Gross Profit | $24.04M | $26.80M | $18.08M | $17.25M |
| Gross Profit Ratio | $0.24 | $0.29 | $0.24 | $0.23 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $9.21M | $7.47M | $7.52M | $6.54M |
| Operating Expenses | $9.21M | $7.47M | $7.52M | $6.54M |
| Total Costs & Expenses | $84.90M | $74.05M | $64.77M | $63.77M |
| Interest Income | $0.00 | $3.000M | $2.52M | $1.96M |
| Interest Expense | $4.56M | $3.000M | $2.52M | $1.96M |
| Depreciation & Amortization | $11.38M | $9.54M | $7.82M | $7.40M |
| EBITDA | $35.82M | $28.87M | $27.48M | $18.11M |
| EBITDA Ratio | $0.36 | $0.31 | $0.24 | $0.24 |
| Operating Income | $14.84M | $19.33M | $10.56M | $10.71M |
| Operating Income Ratio | $0.15 | $0.21 | $0.14 | $0.14 |
| Other Income/Expenses (Net) | $5.04M | -$730571.00 | -$4.17M | -$9.01M |
| Income Before Tax | $19.88M | $18.60M | $17.14M | $11.67M |
| Income Before Tax Ratio | $0.20 | $0.20 | $0.23 | $0.16 |
| Income Tax Expense | $6.79M | $6.33M | $4.17M | $1.18M |
| Net Income | $13.09M | $12.26M | $12.97M | $10.49M |
| Net Income Ratio | $0.13 | $0.13 | $0.17 | $0.14 |
| EPS | $0.04 | $0.04 | $0.05 | $0.04 |
| Diluted EPS | $0.04 | $0.04 | $0.05 | $0.04 |
| Weighted Avg Shares Outstanding | $295.43M | $276.40M | $264.90M | $258.20M |
| Weighted Avg Shares Outstanding (Diluted) | $307.79M | $282.47M | $271.60M | $267.96M |
Over the past four quarters, Acrow Limited demonstrated steady revenue growth, increasing from $74.48M in Q2 2023 to $99.74M in Q4 2024. Operating income reached $14.84M in Q4 2024, maintaining a consistent 15% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $35.82M, reflecting operational efficiency. Net income rose to $13.09M, with EPS at $0.04. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan